PIONEER III

STUDY IDENTIFIER:

PIONEER III

CONDITION:

Coronary Artery Disease

CONTACT INFO:

Amber Antos-Mellang   |   amber.antos@allina.com   |   612-863-8098

DESCRIPTION:

​The primary objective of this trial is to compare the safety and efficacy of the SINOMED BuMA Supreme biodegradable coronary stent in patients with up to 3 coronary lesions to either the XIENCE or Promus durable polymer coronary stents.

CRITERIA LIST/ QUALIFICATIONS:

  • The patient is an acceptable candidate for percutaneous coronary intervention (PCI) with drug-eluting stents

INVESTIGATORS:

M. Nicholas Burke, MD

SPONSORS:

SINOMED / US Subsidiary: NOVA Vascular, LLC

STATUS:

Open/Enrolling